Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Comprehensive assessment of biotin interference in immunoassays.

Li J, Wagar EA, Meng QH.

Clin Chim Acta. 2018 Dec;487:293-298. doi: 10.1016/j.cca.2018.10.013. Epub 2018 Oct 5.

PMID:
30296442
2.

A rapid ultra-performance LC-MS/MS assay for determination of serum unbound fraction of voriconazole in cancer patients.

Li J, Ma J, Wagar EA, Liang D, Meng QH.

Clin Chim Acta. 2018 Nov;486:36-41. doi: 10.1016/j.cca.2018.07.022. Epub 2018 Jul 20.

PMID:
30016626
3.

Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate Cancer.

Cao L, Lee CH, Ning J, Handy BC, Wagar EA, Meng QH.

Arch Pathol Lab Med. 2018 Sep;142(9):1106-1112. doi: 10.5858/arpa.2017-0185-OA. Epub 2018 Mar 16.

PMID:
29547000
4.

Fifteen-Year Journey to High Reliability in Pathology and Laboratory Medicine.

Middleton LP, Phipps R, Routbort M, Prieto V, Medeiros LJ, Riben M, Contreras A, Kelley J, Patel K, Bingham J, Wagar EA.

Am J Med Qual. 2018 Sep/Oct;33(5):530-539. doi: 10.1177/1062860618759198. Epub 2018 Mar 7.

PMID:
29512395
5.

Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer.

Tu H, Gu J, Meng QH, Kim J, Strom S, Davis JW, He Y, Wagar EA, Thompson TC, Logothetis CJ, Wu X.

Oncol Lett. 2017 Mar;13(3):1949-1957. doi: 10.3892/ol.2017.5616. Epub 2017 Jan 18.

6.

Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data.

Wu X, Ye Y, Barcenas CH, Chow WH, Meng QH, Chavez-MacGregor M, Hildebrandt MA, Zhao H, Gu X, Deng Y, Wagar E, Esteva FJ, Tripathy D, Hortobagyi GN.

J Natl Cancer Inst. 2017 Jul 1;109(7). doi: 10.1093/jnci/djw314.

7.

Biomarkers for monitoring chemotherapy-induced cardiotoxicity.

Cao L, Zhu W, Wagar EA, Meng QH.

Crit Rev Clin Lab Sci. 2017 Mar;54(2):87-101. doi: 10.1080/10408363.2016.1261270. Epub 2016 Dec 26. Review.

PMID:
28013560
8.

Where Is the PSA?

Meng QH, Wagar EA.

Clin Chem. 2016 Sep;62(9):1281-2. doi: 10.1373/clinchem.2015.253336. No abstract available.

9.

Causes and impact of specimen rejection in a clinical chemistry laboratory.

Cao L, Chen M, Phipps RA, Del Guidice RE, Handy BC, Wagar EA, Meng QH.

Clin Chim Acta. 2016 Jul 1;458:154-8. doi: 10.1016/j.cca.2016.05.003. Epub 2016 May 7.

PMID:
27166198
10.

Cardiac Troponin Is a Predictor of Septic Shock Mortality in Cancer Patients in an Emergency Department: A Retrospective Cohort Study.

Yang Z, Qdaisat A, Hu Z, Wagar EA, Reyes-Gibby C, Meng QH, Yeung SC.

PLoS One. 2016 Apr 14;11(4):e0153492. doi: 10.1371/journal.pone.0153492. eCollection 2016.

11.

A young boy with recurrent headache, lethargy, and hyponatremia.

Cao L, Wagar EA, Meng QH.

Clin Chim Acta. 2016 Feb 15;454:46-8. doi: 10.1016/j.cca.2015.12.038. Epub 2015 Dec 31.

PMID:
26747959
12.

Cohort Profile: The MD Anderson Cancer Patients and Survivors Cohort (MDA-CPSC).

Wu X, Hildebrandt MA, Ye Y, Chow WH, Gu J, Cunningham S, Zhao H, Hawk ET, Wagar E, Rodriguez A, Hamilton SR.

Int J Epidemiol. 2016 Jun;45(3):713-713f. doi: 10.1093/ije/dyv317. Epub 2015 Dec 20. No abstract available.

13.

Bioterrorism and the Role of the Clinical Microbiology Laboratory.

Wagar E.

Clin Microbiol Rev. 2016 Jan;29(1):175-89. doi: 10.1128/CMR.00033-15. Review.

14.

Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer.

Tu H, Gu J, Meng QH, Kim J, Davis JW, He Y, Wagar EA, Thompson TC, Logothetis CJ, Wu X.

Oncotarget. 2015 Dec 8;6(39):41988-96. doi: 10.18632/oncotarget.5889.

15.

A Patient with Persistent Lactation and Recurrent Hypercalcemia.

Meng QH, Wagar EA.

Clin Chem. 2015 Nov;61(11):1328-31. doi: 10.1373/clinchem.2014.234849. No abstract available.

16.

Evaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection.

Thompson MG, Truong-Le V, Alamneh YA, Black CC, Anderl J, Honnold CL, Pavlicek RL, Abu-Taleb R, Wise MC, Hall ER, Wagar EJ, Patzer E, Zurawski DV.

Antimicrob Agents Chemother. 2015 Oct;59(10):6484-93. doi: 10.1128/AAC.00882-15. Epub 2015 Aug 3.

17.

Falsely elevated tacrolimus concentrations on the Dimension Xpand.

Meng QH, Handy BC, Wagar EA.

Clin Biochem. 2015 Nov;48(16-17):1210. doi: 10.1016/j.clinbiochem.2015.07.002. Epub 2015 Jul 6. No abstract available.

PMID:
26160209
18.

Modulating Acinetobacter baumannii biofilm development with molecules containing 3,4,5-trimethoxy-N,N',N'-trimethylbenzohydrazide moiety.

Sambanthamoorthy K, Hickman M, Pattabiraman N, Palys T, Wagar EJ.

Bioorg Med Chem Lett. 2015;25(10):2238-42. doi: 10.1016/j.bmcl.2015.03.005. Epub 2015 Mar 10.

PMID:
25881818
19.

Red blood cell transfusion practices: a College of American Pathologists Q-Probes study of compliance with audit criteria in 128 hospitals.

Ramsey G, Wagar EA, Grimm EE, Friedberg RC, Souers RJ, Lehman CM.

Arch Pathol Lab Med. 2015 Mar;139(3):351-5. doi: 10.5858/arpa.2013-0756-CP.

PMID:
25724032
20.

A Call to Standardize Preanalytic Data Elements for Biospecimens, Part II.

Robb JA, Bry L, Sluss PM, Wagar EA, Kennedy MF; College of American Pathologists Diagnostic Intelligence and Health Information Technology Biorepository Working Group 2.

Arch Pathol Lab Med. 2015 Sep;139(9):1125-8. doi: 10.5858/arpa.2014-0572-CP. Epub 2015 Jan 16.

PMID:
25594725
21.

Laboratory approaches for the diagnosis and assessment of hypercalcemia.

Meng QH, Wagar EA.

Crit Rev Clin Lab Sci. 2015;52(3):107-19. doi: 10.3109/10408363.2014.970266. Epub 2014 Oct 20. Review.

PMID:
25327435
22.

Pseudohyperkalemia: A new twist on an old phenomenon.

Meng QH, Wagar EA.

Crit Rev Clin Lab Sci. 2015;52(2):45-55. doi: 10.3109/10408363.2014.966898. Epub 2014 Oct 16. Review.

PMID:
25319088
23.

Twenty (forward looking) questions.

Hassell LA, Wagar EA.

J Pathol Inform. 2014 Jul 30;5(1):27. doi: 10.4103/2153-3539.137731. eCollection 2014. No abstract available.

24.

Real-time Leishmania genus master mix: a platform compatibility and stability study.

Melanson VR, Scheirer JL, Kalina WV, Wagar EJ.

Diagn Microbiol Infect Dis. 2014 Oct;80(2):97-101. doi: 10.1016/j.diagmicrobio.2014.07.002. Epub 2014 Jul 17.

PMID:
25112901
25.

Credibility.

Wagar EA.

Arch Pathol Lab Med. 2014 Jul;138(7):873-5. doi: 10.5858/arpa.2014-0151-ED. No abstract available.

PMID:
24978912
26.

Severe hypophosphatemia in a 79-year-old man.

Meng QH, Wagar EA.

Clin Chem. 2014 Jul;60(7):928-31. doi: 10.1373/clinchem.2013.210534. No abstract available.

27.

A case of green blood.

Meng QH, Handy B, Wagar E.

Clin Chem. 2014 Apr;60(4):695-6. doi: 10.1373/clinchem.2013.210062. No abstract available.

28.

Inpatient preanalytic process improvements.

Wagar EA, Phipps R, Del Guidice R, Middleton LP, Bingham J, Prejean C, Johnson-Hamilton M, Philip P, Le NH, Muses W.

Arch Pathol Lab Med. 2013 Dec;137(12):1753-60. doi: 10.5858/arpa.2012-0458-OA.

PMID:
24283855
29.

It's not easy being blue-green.

Meng QH, Handy B, Wagar EA.

Ann Lab Med. 2013 Nov;33(6):457-8. doi: 10.3343/alm.2013.33.6.457. Epub 2013 Oct 17. No abstract available.

30.

Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome.

Meng QH, Xu E, Hildebrandt MA, Liang D, Lu K, Ye Y, Wagar EA, Wu X.

Clin Chem. 2014 Jan;60(1):222-32. doi: 10.1373/clinchem.2013.211490. Epub 2013 Oct 21.

31.

Confirmatory testing of urine ketones and bilirubin: still necessary?

Meng QH, Handy B, Wagar E.

Arch Pathol Lab Med. 2013 Aug;137(8):1028-9. doi: 10.5858/arpa.2013-0054-LE. No abstract available. Erratum in: Arch Pathol Lab Med. 2013 Nov;137(11):1538.

PMID:
23899056
32.

Utilization of stat test priority in the clinical laboratory: a College of American Pathologists q-probes study of 52 institutions.

Volmar KE, Wilkinson DS, Wagar EA, Lehman CM.

Arch Pathol Lab Med. 2013 Feb;137(2):220-7. doi: 10.5858/arpa.2012-0100-CP.

PMID:
23368864
33.

Malaria and other vector-borne infection surveillance in the U.S. Department of Defense Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance program: review of 2009 accomplishments.

Fukuda MM, Klein TA, Kochel T, Quandelacy TM, Smith BL, Villinski J, Bethell D, Tyner S, Se Y, Lon C, Saunders D, Johnson J, Wagar E, Walsh D, Kasper M, Sanchez JL, Witt CJ, Cheng Q, Waters N, Shrestha SK, Pavlin JA, Lescano AG, Graf PC, Richardson JH, Durand S, Rogers WO, Blazes DL, Russell KL; AFHSC-GEIS Malaria and Vector Borne Infections Writing Group, Akala H, Gaydos JC, DeFraites RF, Gosi P, Timmermans A, Yasuda C, Brice G, Eyase F, Kronmann K, Sebeny P, Gibbons R, Jarman R, Waitumbi J, Schnabel D, Richards A, Shanks D.

BMC Public Health. 2011 Mar 4;11 Suppl 2:S9. doi: 10.1186/1471-2458-11-S2-S9. Review.

34.

Training initiatives within the AFHSC-Global Emerging Infections Surveillance and Response System: support for IHR (2005).

Otto JL, Baliga P, Sanchez JL, Johns MC, Gray GC, Grieco J, Lescano AG, Mothershead JL, Wagar EJ, Blazes DL; AFHSC-GEIS Training Writing Group, Achila R, Baker W, Blair P, Brown M, Bulimo W, Byarugaba D, Coldren R, Cooper M, Ducatez M, Espinosa B, Ewings P, Guerrero A, Hawksworth T, Jackson C, Klena JD, Kraus S, Macintosh V, Mansour M, Maupin G, Maza J, Montgomery J, Ndip L, Pavlin J, Quintana M, Richard W, Rosenau D, Saeed T, Sinclair L, Smith I, Smith J, Styles T, Talaat M, Tobias S, Vettori J, Villinski J, Wabwire-Mangen F.

BMC Public Health. 2011 Mar 4;11 Suppl 2:S5. doi: 10.1186/1471-2458-11-S2-S5. Review.

35.

A review of sentinel laboratory performance: identification and notification of bioterrorism agents.

Wagar EA, Mitchell MJ, Carroll KC, Beavis KG, Petti CA, Schlaberg R, Yasin B.

Arch Pathol Lab Med. 2010 Oct;134(10):1490-503. doi: 10.1043/2010-0098-CP.1.

PMID:
20923306
36.

Document control practices in 120 clinical laboratories.

Valenstein PN, Stankovic AK, Souers RJ, Schneider F, Wagar EA.

Arch Pathol Lab Med. 2009 Jun;133(6):942-9. doi: 10.1043/1543-2165-133.6.942.

PMID:
19492888
37.

Notification of critical results: a College of American Pathologists Q-Probes study of 121 institutions.

Valenstein PN, Wagar EA, Stankovic AK, Walsh MK, Schneider F.

Arch Pathol Lab Med. 2008 Dec;132(12):1862-7. doi: 10.1043/1543-2165-132.12.1862.

PMID:
19061281
38.

Specimen labeling errors: a Q-probes analysis of 147 clinical laboratories.

Wagar EA, Stankovic AK, Raab S, Nakhleh RE, Walsh MK.

Arch Pathol Lab Med. 2008 Oct;132(10):1617-22. doi: 10.1043/1543-2165(2008)132[1617:SLEAQA]2.0.CO;2.

PMID:
18834220
39.

Urine culture contamination: a College of American Pathologists Q-Probes study of 127 laboratories.

Bekeris LG, Jones BA, Walsh MK, Wagar EA.

Arch Pathol Lab Med. 2008 Jun;132(6):913-7. doi: 10.1043/1543-2165(2008)132[913:UCCACO]2.0.CO;2.

PMID:
18517272
40.

Critical values comparison: a College of American Pathologists Q-Probes survey of 163 clinical laboratories.

Wagar EA, Friedberg RC, Souers R, Stankovic AK.

Arch Pathol Lab Med. 2007 Dec;131(12):1769-75.

PMID:
18081434
41.

The laboratory and patient safety.

Wagar EA, Yuan S.

Clin Lab Med. 2007 Dec;27(4):909-30, viii-ix. Review.

PMID:
17950905
42.

The origin of reference intervals.

Friedberg RC, Souers R, Wagar EA, Stankovic AK, Valenstein PN; College of American Pathologists.

Arch Pathol Lab Med. 2007 Mar;131(3):348-57.

PMID:
17516737
43.

Assessment monitoring of laboratory critical values: a College of American Pathologists Q-Tracks study of 180 institutions.

Wagar EA, Stankovic AK, Wilkinson DS, Walsh M, Souers RJ.

Arch Pathol Lab Med. 2007 Jan;131(1):44-9.

PMID:
17227122
44.

Patient safety in the clinical laboratory: a longitudinal analysis of specimen identification errors.

Wagar EA, Tamashiro L, Yasin B, Hilborne L, Bruckner DA.

Arch Pathol Lab Med. 2006 Nov;130(11):1662-8.

PMID:
17076528
45.

Some physical and microstructural properties of genipin-crosslinked gelatin-maltodextrin hydrogels.

Nickerson MT, Farnworth R, Wagar E, Hodge SM, Rousseau D, Paulson AT.

Int J Biol Macromol. 2006 Feb 28;38(1):40-4. Epub 2006 Jan 26.

PMID:
16443267
46.

The External RNA Controls Consortium: a progress report.

Baker SC, Bauer SR, Beyer RP, Brenton JD, Bromley B, Burrill J, Causton H, Conley MP, Elespuru R, Fero M, Foy C, Fuscoe J, Gao X, Gerhold DL, Gilles P, Goodsaid F, Guo X, Hackett J, Hockett RD, Ikonomi P, Irizarry RA, Kawasaki ES, Kaysser-Kranich T, Kerr K, Kiser G, Koch WH, Lee KY, Liu C, Liu ZL, Lucas A, Manohar CF, Miyada G, Modrusan Z, Parkes H, Puri RK, Reid L, Ryder TB, Salit M, Samaha RR, Scherf U, Sendera TJ, Setterquist RA, Shi L, Shippy R, Soriano JV, Wagar EA, Warrington JA, Williams M, Wilmer F, Wilson M, Wolber PK, Wu X, Zadro R; External RNA Controls Consortium.

Nat Methods. 2005 Oct;2(10):731-4.

PMID:
16179916
47.
48.

Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.

Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI.

J Virol. 2004 May;78(10):5147-56.

49.

Management training for pathology residents: a regional approach.

Horowitz RE, Naritoku W, Wagar EA.

Arch Pathol Lab Med. 2004 Jan;128(1):59-63.

PMID:
14692810
50.

Supplemental Content

Support Center